Clinical Trials on Primary Hyperoxaluria Type 3 in Japan
Total 211 results
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc.CompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Advanced Cancer | Biliary Tract Carcinoma | Gall Bladder CarcinomaJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid CarcinomaJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid Carcinoma | HypercalcemiaJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Okayama UniversityCompletedType 2 Diabetes Mellitus | Diabetic NephropathyJapan
-
Shiga UniversityCompleted
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Shinshu UniversityKowa Company, Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus) | Metformin | SGLT2-InhibitorsJapan
-
Genzyme, a Sanofi CompanyActive, not recruitingGaucher Disease Type 1 | Gaucher Disease Type 3Germany, United States, Japan, United Kingdom
-
Kyowa Kirin Co., Ltd.CompletedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
TakedaCompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)RecruitingFallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant CarriersJapan
-
Dokkyo Medical UniversityCompletedHypertension | Diabetic Nephropathy | Type 2 Diabetes | DyslipidemiaJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Ferring PharmaceuticalsCompletedHepatorenal Syndrome Type 1Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
City of Hope Medical CenterRecruitingHepatocellular Carcinoma | Primary Liver Cancer | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Hepatic Cancer | Hepatic Carcinoma | Primary Liver CarcinomaUnited States, Japan
-
Shiga UniversityOsaka University; Kanazawa Medical University; Nagahama Red Cross Hospital; Nagahama... and other collaboratorsUnknownType 2 Diabetes MellitusJapan
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellJapan
-
Bristol-Myers SquibbCompletedKidney Cancer | Renal Cell CarcinomaJapan
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Yamagata UniversityUnknownMetastatic Renal Cell CarcinomaJapan
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
BayerCompletedCarcinoma, Renal CellJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompletedKidney Cancer | Renal CancerJapan
-
Saga UniversityActive, not recruitingChronic Kidney Diseases | Type 2 DiabetesJapan
-
Daiichi Sankyo Co., Ltd.Completed
-
Eisai Co., Ltd.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
BayerCompleted
-
Kitasato UniversityYokohama City University Medical Center; St. Marianna University School of... and other collaboratorsUnknownHypertension | Type 2 Diabetes MellitusJapan
-
Tokyo Medical and Dental UniversityWithdrawnHepatocellular Carcinoma | Cholangiocarcinoma | Gallbladder Neoplasms | HepatomaJapan
-
TakedaCompleted
-
Daiichi Sankyo Co., Ltd.CompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | ProteinuriaJapan, China
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Tokyo Women's Medical UniversityCompletedKidney Cancer | Metastatic CancerJapan
-
Chugai PharmaceuticalCompleted
-
SanofiRecruitingGaucher's Disease Type IIIUnited States, Germany, Hungary, France, China, Japan, Canada, Argentina, Italy, Turkey
-
PfizerCompletedRenal Cell CarcinomaJapan
-
TakedaRecruiting
-
Telix International Pty LtdCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan